Schlößer et al. revealed the presence of GLUT 3 in 66% of the human primary gastric cancer or adenocarcinoma of the gastroesophageal junction, and higher expression of GLUT 3 was associated with advanced UICC stage of cancer. The gene discussed is SLC2A3; the disease is adenocarcinoma.